| Connecting bioconjugate science, technology, and application across industries Bioconjugate Insights is an open-access, peer-reviewed journal providing industry-aligned strategic analysis and technical updates across the bioconjugate field. Covering ADCs, linker, and payload innovation, conjugation chemistry, analytics, regulation, and manufacturing. We connect research with translational and commercial perspectives to support smarter development of bioconjugate therapies. Sign-up for free to gain unlimited access to our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the cutting edge of bioconjugate innovation. | ![]() |
In this issue, we examine how linker chemistry has become a central lever for defining the therapeutic window. Explore why the whole ADC molecule has to be designed as one, and chart a bioconjugate landscape where developers are increasingly differentiating on construct rather than target.
"Parts of an ADC cannot be designed in isolation; the whole molecule has to be considered."– Michael Lukesch, Founder and CEO, Valanx
"The linker cannot be optimized independently of the payload or the antibody, and it cannot be divorced from the target biology."– Brian A Mendelsohn, Independent Industry Consultant and ADC Veteran
| Your content marketing partner for life sciences BioInsights is a global content marketing and demand generation partner for the life sciences industry. With a community of 60,000+ registered users spanning biotech, pharma, academia, and solution providers, we help you reach the people that matter, through tailored content strategies, high-impact lead generation, and expert-led publishing across every major biopharma modality. Explore the media kit to find out more about our offering or contact us to see how we can support your marketing efforts. View our media kit | ![]() |
| Our journals Our portfolio of four open access journals provides trusted insight across the advanced therapies landscape. Cell & Gene Therapy Insights, Bioconjugate Insights, Vaccine Insights, and Nucleic Acids Insights deliver expert commentary, original research, and practical guidance that help researchers, developers, and manufacturers stay aligned with the rapidly evolving needs of modern biomedicine. Each journal focuses on translating innovation into real-world impact, giving readers clear, actionable knowledge that supports progress from discovery through to clinical and commercial success. Want to keep up with the latest journal content and upcoming webinars? | View | View | View | View |
FAQs |
| Get in touch Ready to connect? Our team is here to answer questions, explore ideas, and help you get the most from your partnership with BioInsights. Reach out and let us know how we can support you. Contact us |
| Bioconjugate Insights | Cell & Gene Therapy Insights | Nucleic Acid Insights | Vaccine Insights |